Literature DB >> 15674089

Drug-induced acute liver failure.

Dominique Larrey1, Georges-Philippe Pageaux.   

Abstract

Acute liver failure is the most severe expression and represents the first cause of fatalities related to drugs. As a consequence, it is also the first cause of drug withdrawal from the pharmaceutical market. The incidence of drug-induced hepatotoxicity in the general population has been recently estimated to be around 14/100,000 inhabitants in a Western country. Drugs appear to be responsible for 10-52% of all causes of acute liver failure. In Western countries, paracetamol (acetaminophen) represents the first cause of all liver failures. The contribution of non-paracetamol drugs given at normal doses is equivalent to that of combined viral hepatitis A and B. The natural prognosis varies between drugs. The spontaneous mortality rate ranges from 32% to 50% for paracetamol intoxication and more than 75% for other drugs. The preventive occurrence of drug hepatotoxicity and the course to acute liver failure is rather limited. It is recommended to stop the administration of a suspected drug when alanine aminotransferase levels increase to more than 3-5 times the upper limit of normal. In paracetamol intoxication, the rapid administration of N-acetylcysteine is a classical antidote. At the stage of liver failure, treatment is mostly supportive. Since irreversible damage is unpredictable, early transfer to a transplantation centre should be considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15674089     DOI: 10.1097/00042737-200502000-00002

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  16 in total

1.  Nimesulide-induced hepatotoxicity in a previously healthy woman.

Authors:  L Gallelli; M Ferraro; G F Mauro; S De Fazio; G De Sarro
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

2.  Ethanol extract from portulaca oleracea L. attenuated acetaminophen-induced mice liver injury.

Authors:  Xue-Feng Liu; Cheng-Gang Zheng; Hong-Guang Shi; Gu-Sheng Tang; Wan-Yin Wang; Juan Zhou; Li-Wei Dong
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells.

Authors:  Lei Guo; Lu Zhang; Yongming Sun; Levan Muskhelishvili; Ernice Blann; Stacey Dial; Leming Shi; Gary Schroth; Yvonne P Dragan
Journal:  Mol Divers       Date:  2006-09-21       Impact factor: 2.943

4.  Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.

Authors:  Adrian Reuben; David G Koch; William M Lee
Journal:  Hepatology       Date:  2010-10-14       Impact factor: 17.425

5.  Blood gene expression signatures predict exposure levels.

Authors:  P R Bushel; A N Heinloth; J Li; L Huang; J W Chou; G A Boorman; D E Malarkey; C D Houle; S M Ward; R E Wilson; R D Fannin; M W Russo; P B Watkins; R W Tennant; R S Paules
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-02       Impact factor: 11.205

Review 6.  Causality assessment in hepatotoxicity by drugs and dietary supplements.

Authors:  Rolf Teschke; Alexander Schwarzenboeck; Karl-Heinz Hennermann
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

7.  Fatal fulminant hepatitis E associated with autoimmune hepatitis and excessive paracetamol intake in Southeastern France.

Authors:  Barbara Doudier; Hugues Vencatassin; Sarah Aherfi; Philippe Colson
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

Review 8.  Remote ischemic preconditioning as treatment for non-ischemic gastrointestinal disorders: beyond ischemia-reperfusion injury.

Authors:  Carlos Rodrigo Camara-Lemarroy
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 9.  Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital.

Authors:  Pengcheng Ou; Yi Chen; Chengwei Chen; Baozhen Li; Min Zhang; Xingyu Liu; Fangfang Li; Yi Li; Yimin Mao; Jun Chen
Journal:  Springerplus       Date:  2015-12-22

10.  Subtoxic Concentrations of Hepatotoxic Drugs Lead to Kupffer Cell Activation in a Human In Vitro Liver Model: An Approach to Study DILI.

Authors:  Victoria Kegel; Elisa Pfeiffer; Britta Burkhardt; Jia L Liu; Katrin Zeilinger; Andreas K Nüssler; Daniel Seehofer; Georg Damm
Journal:  Mediators Inflamm       Date:  2015-09-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.